MedTrace Logo

Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery

NCT00123539 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 334

Last updated 2016-07-29

No results posted yet for this study

Summary

The purpose of this study is to test whether perioperative estrogen replacement in postmenopausal women reduces the risk for neurologic injury after coronary artery bypass graft (CABG) surgery.

Conditions

Interventions

DRUG

Estrogen Replacement Therapy

PROCEDURE

Surgery

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Charles W. Hogue, Jr., MD · Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE

Eligibility

Min Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-06-30
Completion
2005-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00123539 on ClinicalTrials.gov